Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRALOKINUMAB-LDRM for Dermatitis atopic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,007 adverse event reports in the FDA FAERS database where TRALOKINUMAB-LDRM was used for Dermatitis atopic.

Most Reported Side Effects for TRALOKINUMAB-LDRM

Side Effect Reports % Deaths Hosp.
Dermatitis atopic 613 14.9% 0 12
Drug ineffective 461 11.2% 1 5
Pruritus 365 8.9% 0 10
Rash 266 6.5% 1 10
Injection site pain 206 5.0% 1 5
Injection site erythema 136 3.3% 0 1
Dry skin 135 3.3% 0 1
Erythema 133 3.2% 0 3
Eczema 129 3.1% 0 4
Injection site pruritus 124 3.0% 0 1
Injection site swelling 119 2.9% 0 3
Eye pruritus 106 2.6% 0 1
Ocular hyperaemia 105 2.6% 0 0
Urticaria 97 2.4% 0 3
Product use in unapproved indication 96 2.3% 2 11

Other Indications for TRALOKINUMAB-LDRM

Product used for unknown indication (606) Eczema (170) Dermatitis (90) Psoriasis (55) Neurodermatitis (46) Dermatitis allergic (41) Asthma (17) Pruritus (16) Dermatitis contact (10) Eczema nummular (8)

Other Drugs Used for Dermatitis atopic

DUPILUMAB (179,563) UPADACITINIB (5,263) CRISABOROLE (2,139) ABROCITINIB (1,616) NEMOLIZUMAB-ILTO (1,596) RUXOLITINIB (740) TACROLIMUS (515) METHOTREXATE (400) CYCLOSPORINE (370) LEBRIKIZUMAB-LBKZ (312)

Related Pages

TRALOKINUMAB-LDRM Full Profile All Dermatitis atopic Drugs TRALOKINUMAB-LDRM Demographics TRALOKINUMAB-LDRM Timeline